Today: 9 April 2026
Bank of America stock: BAC dips premarket after Q4 beat as interest-income outlook takes center stage
14 January 2026
2 mins read

Bank of America stock: BAC dips premarket after Q4 beat as interest-income outlook takes center stage

New York, January 14, 2026, 08:41 EST — Premarket update.

  • BAC slips roughly 1.2% in premarket following its Q4 earnings report
  • Bank highlighted a jump in net interest income alongside robust equities trading for the quarter
  • Investors will be listening closely to the 8:30 a.m. ET call for insights on the 2026 outlook covering rates, costs, and credit

Bank of America (BAC) slipped 1.2% in premarket action Wednesday, trading at $54.54, below Tuesday’s close of $55.22.

Bank of America delivered a fourth-quarter profit that outpaced Wall Street’s estimates and maintained its forecast for higher net interest income this year. The lender posted net income of $7.6 billion, or 98 cents per share, surpassing the 96 cents per share analysts had anticipated, according to LSEG data. It also projected a 7% increase in first-quarter net interest income and reaffirmed its 5% to 7% growth outlook for fiscal 2026. Reuters

This matters now as investors sift through bank earnings amid a cycle of easing rates. Net interest income — the gap between what banks earn on loans versus what they pay on deposits — can swing when rates drop quicker than loans get repriced. For BAC, the key question is whether its interest income bounce-back will last if the Fed cuts rates again.

Bank of America reported a 7% rise in fourth-quarter revenue, hitting $28.4 billion, with net interest income climbing 10% to $15.8 billion. Sales and trading revenue jumped 10% to $4.5 billion, led by a 23% surge in equities revenue to around $2.0 billion. The bank reserved $1.3 billion for credit losses and posted a 4% increase in noninterest expenses, totaling $17.4 billion. CEO Brian Moynihan said, “With consumers and businesses proving resilient … we expect further economic growth in the year ahead.” CFO Alastair Borthwick highlighted “strong liquidity and capital” after returning $8.4 billion to shareholders via dividends and buybacks. SEC

The premarket slide hints that some investors are reacting to more than just the earnings beat. Cost pressures, buyback activity, and shifts in credit trends can shake a big bank stock more sharply than the headline numbers. The market’s growing uneasy over what “normal” trading revenue means after a wild quarter.

Wells Fargo’s Q4 results underscored just how tight expectations remain. The bank fell short of analysts’ profit and net interest income estimates, pushing its shares down roughly 1.7% in premarket trading. Reuters

Citigroup reported on Wednesday, revealing quarterly profits dragged down by a charge linked to its exit from Russia. Yet, dealmaking and services showed strength, highlighting just how varied this earnings season is from one bank to another. Reuters

Investors are keeping an eye on Washington as well. A one-year cap on credit card interest rates, supported by President Donald Trump, could lower borrowing costs for certain consumers. However, analysts warn it might squeeze bank profits and reduce credit availability if passed. Reuters

The road ahead isn’t straightforward. Quicker rate cuts might reduce interest income more than anticipated, and a weakening labor market could strain consumer credit, driving up provisions. The trading boost seen this quarter usually loses momentum once volatility subsides.

All eyes turn to management’s remarks during Bank of America’s earnings call at 8:30 a.m. ET Wednesday. Investors are set to dig into deposit pricing, cost controls, and the assumptions driving the 2026 net interest income outlook. investor.bankofamerica.com

Stock Market Today

  • Guard Therapeutics Faces Potential Delisting from Nasdaq First North Growth Market
    April 9, 2026, 12:06 PM EDT. Guard Therapeutics International AB has been notified by Nasdaq that it currently fails to meet the active operations requirement, risking delisting by June 17, 2026. The company is exploring a merger or reverse acquisition to satisfy Nasdaq's operational criteria. A transaction structure is expected to be proposed in Q2 2024, allowing Nasdaq to reassess the listing status. If no agreement is reached, the board will recommend voluntary delisting and liquidation, returning available funds to shareholders. Final decisions will be taken by shareholders at a general meeting. Guard Therapeutics focuses on developing therapies for kidney diseases based on the alpha-1-microglobulin protein and is listed under the ticker GUARD.

Latest article

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

9 April 2026
Palantir Technologies dropped about 7% Thursday after Michael Burry said Anthropic was overtaking it in enterprise AI, putting Palantir on track to lose $34 billion in market value. Anthropic reported its annualized revenue run rate had surged past $30 billion and launched new AI tools for businesses. Nearly one in four businesses on Ramp now pays for Anthropic, according to Ramp data. Palantir’s stock still trades at 395 times earnings.
Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

9 April 2026
Salesforce shares hit a new 52-week low Thursday, dropping 3.7% to $169.76 despite reporting 12% revenue growth and strong demand for its AI products. The broader software sector continued to slide, with the S&P 500 software and services index down about $1 trillion since January. Salesforce raised its buyback authorization to $50 billion and increased its dividend to 44 cents a share.
ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

9 April 2026
ServiceNow shares dropped 5.1% to $92.45 by 10:20 a.m. EDT Thursday, hitting a new 52-week low after analysts at Stifel, BTIG, and Goldman Sachs cut price targets citing weak federal spending and limited 2026 growth. The company announced it will integrate AI, data, security, and governance into all products ahead of first-quarter results due April 22.
SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

9 April 2026
SoFi Technologies shares fell 1.9% to $16.18 Thursday after KBW and Wells Fargo cut price targets ahead of first-quarter results due April 29. The moves follow Muddy Waters’ short position and claims of accounting issues, which SoFi denies. Affirm and LendingClub also traded lower. Barclays and other banks have trimmed targets as concerns mount over credit quality and sector valuations.
Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

9 April 2026
Tesla is developing a smaller, cheaper electric SUV to be built first in Shanghai, sources said. The new model would cost less than the Model 3 and be smaller than the Model Y. Tesla produced 408,386 vehicles but delivered only 358,023 in Q1, as U.S. demand weakened and competition increased. Shares fell 0.8% Thursday.
EB Games New Zealand to close all stores by Jan 31 — what happens to gift cards and preorders
Previous Story

EB Games New Zealand to close all stores by Jan 31 — what happens to gift cards and preorders

Progressive stock steadies premarket after 5% slide as Mizuho trims target again
Next Story

Progressive stock steadies premarket after 5% slide as Mizuho trims target again

Go toTop